- Home
- HYPR vs BRNS Comparison
HYPR vs BRNS Comparison
Compare HYPR & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HYPR
- BRNS
- Stock Information
- Founded
- HYPR 2014
- BRNS 2016
- Country
- HYPR United States
- BRNS United Kingdom
- Employees
- HYPR N/A
- BRNS N/A
- Industry
- HYPR Medical Specialities
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- HYPR Health Care
- BRNS Health Care
- Exchange
- HYPR Nasdaq
- BRNS Nasdaq
- Market Cap
- HYPR 55.9M
- BRNS 48.3M
- IPO Year
- HYPR N/A
- BRNS 2021
- Fundamental
- Price
- HYPR $1.41
- BRNS $1.07
- Analyst Decision
- HYPR Strong Buy
- BRNS Strong Buy
- Analyst Count
- HYPR 3
- BRNS 1
- Target Price
- HYPR $1.28
- BRNS $3.00
- AVG Volume (30 Days)
- HYPR 250.4K
- BRNS 42.9K
- Earning Date
- HYPR 11-11-2025
- BRNS 11-05-2025
- Dividend Yield
- HYPR N/A
- BRNS N/A
- EPS Growth
- HYPR N/A
- BRNS N/A
- EPS
- HYPR N/A
- BRNS N/A
- Revenue
- HYPR $10,797,000.00
- BRNS $14,969,000.00
- Revenue This Year
- HYPR $12.92
- BRNS N/A
- Revenue Next Year
- HYPR $32.10
- BRNS N/A
- P/E Ratio
- HYPR N/A
- BRNS N/A
- Revenue Growth
- HYPR N/A
- BRNS 1766.46
- 52 Week Low
- HYPR $0.53
- BRNS $0.64
- 52 Week High
- HYPR $1.90
- BRNS $2.92
- Technical
- Relative Strength Index (RSI)
- HYPR 64.64
- BRNS 41.80
- Support Level
- HYPR $1.36
- BRNS $1.08
- Resistance Level
- HYPR $1.47
- BRNS $1.20
- Average True Range (ATR)
- HYPR 0.08
- BRNS 0.10
- MACD
- HYPR 0.01
- BRNS -0.01
- Stochastic Oscillator
- HYPR 79.55
- BRNS 22.16
About HYPR Hyperfine Inc.
Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales which consist of sales from subscriptions of bundled devices, maintenance, and software.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.